Search

Search Constraints

You searched for: Author/Creator Hernando, C.

Search Results

1. Balixafortide (a CXCR4 antagonist) plus eribulin in HER2-negative metastatic breast cancer (MBC): A Phase I open-label trial. (April 2018)